Shi JP - Search Results

1

Promoting the term MAFLD: China in action.

Zhang XL, Fan JG, Wei L, Shi JP, Zheng MH; Chinese MAFLD Clinical Research Network. Zhang XL, et al. Among authors: shi jp. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):598. doi: 10.1016/S2468-1253(22)00127-3. Lancet Gastroenterol Hepatol. 2022. PMID: 35709820 No abstract available.

2

[Prevalence and risk factors of hepatic steatosis in patients with chronic hepatitis B].

Shi JP, Fan JG, Wu R, Gao XQ, Zhang L, Wang H. Shi JP, et al. Zhonghua Gan Zang Bing Za Zhi. 2008 Jul;16(7):519-23. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 18647531 Chinese.

3

Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection.

Shi JP, Fan JG, Wu R, Gao XQ, Zhang L, Wang H, Farrell GC. Shi JP, et al. J Gastroenterol Hepatol. 2008 Sep;23(9):1419-25. doi: 10.1111/j.1440-1746.2008.05531.x. J Gastroenterol Hepatol. 2008. PMID: 18853998

4

[Viral and host causes of hepatosteatosis in Chinese patients with chronic hepatitis B].

Shi JP, Fan JG, Wu R, Gao XQ, Zhang L. Shi JP, et al. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008 Oct;22(5):324-6. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008. PMID: 19469163 Chinese.

5

[Clinical and histological features of non-alcoholic fatty liver disease].

Shi JP, Xun YH, Hu CB, Zhang L, Liu H, Lou GQ, Fan JG. Shi JP, et al. Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):812-6. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19958638 Chinese.

6

[Establishment and identification of non-alcoholic fatty liver disease in chronic hepatitis B virus infected mice].

Zhang Z, Pan Q, Duan XY, Shi JP, Fan JG. Zhang Z, et al. Among authors: shi jp. Zhonghua Gan Zang Bing Za Zhi. 2011 Sep;19(9):658-63. doi: 10.3760/cma.j.issn.1007-3418.2011.09.007. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 22152379 Chinese.

7

[Impact of liver steatosis on antiviral effects of pegylated interferon-alpha in patients with chronic hepatitis B].

Shi JP, Lu L, Qian JC, Ang J, Xun YH, Guo JC, Shi WL, Wang YF, Fan JG. Shi JP, et al. Among authors: shi wl. Zhonghua Gan Zang Bing Za Zhi. 2012 Apr;20(4):285-8. doi: 10.3760/cma.j.issn.1007-3418.2012.04.012. Zhonghua Gan Zang Bing Za Zhi. 2012. PMID: 22964150 Clinical Trial. Chinese.

8

Randomized, vitamin E-controlled trial of bicyclol plus metformin in non-alcoholic fatty liver disease patients with impaired fasting glucose.

Han Y, Shi JP, Ma AL, Xu Y, Ding XD, Fan JG. Han Y, et al. Among authors: shi jp. Clin Drug Investig. 2014 Jan;34(1):1-7. doi: 10.1007/s40261-013-0136-3. Clin Drug Investig. 2014. PMID: 24081374 Clinical Trial.

9

[A brief report on the 5th National Congress of Fatty Liver Disease and 2013 Frontiers Medical Forum in China].

Cao HX, Fan JG, Shi JP, Li YM, Zhuang H. Cao HX, et al. Among authors: shi jp. Zhonghua Gan Zang Bing Za Zhi. 2013 Oct;21(10):799-800. Zhonghua Gan Zang Bing Za Zhi. 2013. PMID: 24579237 Chinese. No abstract available.

10

[A multi-center clinical study of a novel controlled attenuation parameter for assessment of fatty liver].

Shen F, Zheng R, Mi Y, Shi J, Chen G, Chen J, Xu L, Pan Q, Xu L, Fan J. Shen F, et al. Zhonghua Gan Zang Bing Za Zhi. 2014 Dec;22(12):926-31. doi: 10.3760/cma.j.issn.1007-3418.2014.12.010. Zhonghua Gan Zang Bing Za Zhi. 2014. PMID: 25654287 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page